The Innovative Medicines Initiative (IMI), a partnership between the European Union (represented by the European Commission) and the European pharmaceutical industry (represented by the European Federation of Pharmaceutical Industries and Associations (EFPIA) has launched a Call for proposals on COVID-19.

The scope of this fast-track call, with a budget of €45 million, remains broad and focuses on the development of:

• therapeutics to address the current COVID-19 outbreak and/or future coronavirus outbreaks
• development of diagnostics, ensuring rapid evaluation of candidates based on existing technologies
• development of fast and reliable tools that go beyond the state of the art for detection of COVID-19 carriers and symptomatic individuals suspected of COVID-19 infection.

Preventive vaccines are specifically excluded from the scope of the Call.

Full request for proposal